Abstract:GNE myopathy is a rare autosomal recessive disorder caused by mutations in the GNE gene, which is essential for the sialic acid biosynthesis pathway. Although over 200 GNE variants have been reported, some patients remain undiagnosed with only one heterozygous mutation. This study aims to analyse the entire GNE genomic region to identify novel mutations. Patients with clinically compatible GNE myopathy and mono-allelic mutations in the GNE gene were enrolled. The other GNE mutation was searched using a combination of Sanger sequencing, targeted next-generation sequencing (NGS), exon2 qPCR, and Nanopore long-read single-molecule sequencing (LRS). Verification of pseudoexons was performed by RT-PCR and sequencing of complementary DNA (cDNA) derived from frozen skeletal muscle tissue. Ten patients were enrolled, who exhibited typical symptoms, such as foot drop, walking difficulty, or distal weakness affecting both hands and lower legs. Three patients had idiopathic thrombocytopenia (ITP) and one had increased platelet count. The median age at onset was 33 years (25-44 years). A novel deep intronic variant (DIV), c.862+870C>T, was detected in nine patients from eight unrelated families. It was predicted by SpliceAI to create new splice donor sites and lead to pseudoexon inclusion. Splice-site strength scoring methods supported these predictions, indicating high probabilities of abnormal splicing. RT-PCR and sequencing of cDNA derived from muscle tissues revealed a 146 bp inserted fragment between GNE exon 5 and 6, which would result in a premature stop codon. RNA sequencing confirmed abnormal GNE splicing and expression, causing the inclusion of a pathogenic pseudoexon in GNE mRNA. This study identified a novel deep intronic disease-causing mutation in the GNE gene. It located at the allosteric region of the UDP-GlcNAc-2-epimerase (GNE) domain, which is also associated with ITP. Further research is necessary to better understand the molecular mechanisms underlying thrombocytopenia resulted from this mutation. The discovery of novel mutations in GNE, such as the deep intronic mutation activating pseudoexon inclusion, expanded the mutational spectrum of GNE myopathy. A modified genetic test algorithm covering the entire region of GNE gene will optimize the molecular diagnosis in the future. GNE myopathy is a rare autosomal recessive disorder caused by mutations in the GNE gene, which is essential for the sialic acid biosynthesis pathway. Although over 200 GNE variants have been reported, some patients remain undiagnosed with only one heterozygous mutation. This study aims to analyse the entire GNE genomic region to identify novel mutations. Patients with clinically compatible GNE myopathy and mono-allelic mutations in the GNE gene were enrolled. The other GNE mutation was searched using a combination of Sanger sequencing, targeted next-generation sequencing (NGS), exon2 qPCR, and Nanopore long-read single-molecule sequencing (LRS). Verification of pseudoexons was performed by RT-PCR and sequencing of complementary DNA (cDNA) derived from frozen skeletal muscle tissue. Ten patients were enrolled, who exhibited typical symptoms, such as foot drop, walking difficulty, or distal weakness affecting both hands and lower legs. Three patients had idiopathic thrombocytopenia (ITP) and one had increased platelet count. The median age at onset was 33 years (25-44 years). A novel deep intronic variant (DIV), c.862+870C>T, was detected in nine patients from eight unrelated families. It was predicted by SpliceAI to create new splice donor sites and lead to pseudoexon inclusion. Splice-site strength scoring methods supported these predictions, indicating high probabilities of abnormal splicing. RT-PCR and sequencing of cDNA derived from muscle tissues revealed a 146 bp inserted fragment between GNE exon 5 and 6, which would result in a premature stop codon. RNA sequencing confirmed abnormal GNE splicing and expression, causing the inclusion of a pathogenic pseudoexon in GNE mRNA. This study identified a novel deep intronic disease-causing mutation in the GNE gene. It located at the allosteric region of the UDP-GlcNAc-2-epimerase (GNE) domain, which is also associated with ITP. Further research is necessary to better understand the molecular mechanisms underlying thrombocytopenia resulted from this mutation. The discovery of novel mutations in GNE, such as the deep intronic mutation activating pseudoexon inclusion, expanded the mutational spectrum of GNE myopathy. A modified genetic test algorithm covering the entire region of GNE gene will optimize the molecular diagnosis in the future.

A deep intronic variant in MME causes autosomal recessive Charcot–Marie–Tooth neuropathy through aberrant splicing

Genetic Spectrum of MCM3AP and Its Relationship with Phenotype of Charcot‐Marie‐Tooth Disease

A polymorphic AT-repeat causes frequent allele dropout for an MME mutational hotspot exon

Variants in MME are associated with autosomal-recessive distal hereditary motor neuropathy

A nonsense mutation in MME gene associates with autosomal recessive late-onset Charcot-Marie-Tooth disease

A Novel Missense Mutation in Peripheral Myelin Protein-22 Causes Charcot-Marie-Tooth Disease

Pathogenic deep intronic MTM1 variant activates a pseudo-exon encoding a nonsense codon resulting in severe X-linked myotubular myopathy

A novel splicing mutation in 5'UTR of GJB1 causes X-linked Charcot-Marie-tooth disease

Mutations in MME cause an autosomal‐recessive Charcot–Marie–Tooth disease type 2

Biallelic variants in cause a mitochondrial disorder primarily manifesting as peripheral neuropathy

Mutation in the Gene Encoding Ubiquitin Ligase LRSAM1 in Patients with Charcot-Marie-Tooth Disease

P160 A Deep Intronic Variant C.862+870c>t Correlated with GNE Myopathy and Thrombocytopenia

Characterising the phenotype and mode of inheritance of patients with inherited peripheral neuropathies carrying MME mutations

Identification of a Novel Deep Intronic Variant by Whole Genome Sequencing Combined With RNA Sequencing in a Chinese Patient With Menkes Disease

Case Report: Charcot-marie-tooth disease caused by a de novo MORC2 gene mutation - novel insights into pathogenicity and treatment

Biallelic variants in COX18 cause a mitochondrial disorder primarily manifesting as peripheral neuropathy

A novel variant of biallelic MME gene associated with autosomal recessive late-onset distal hereditary motor neuropathy in Chinese families

Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease

Hereditary axonal neuropathy related to MME gene mutation in a family with fetomaternal alloimmune glomerulonephritis

Pseudoexon activation by deep intronic variation in GNE myopathy with thrombocytopenia

Identification of a Novel Homozygous Mutation in MTMR2 Gene Causes Very Rare Charcot-Marie-Tooth Disease Type 4B1